Together, they create an environment where natural GLP-1 production is maximally supported through multiple independent pathways
Pleasure-in-care is that thing that our unconscious is crying out for, and were giving it products instead
insurance, HSA, and FSA applicability
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Notably, sKER-065, is an investigational new drug developed by Keros Therapeutics with a unique design
Its also the first to show a reduction in autoimmune disease with GLP-1 meds. Noninfectious uveitis is often associated with autoimmune disease, such as sarcoidosis, juvenile idiopathic arthritis and ankylosing spondylitis